PB

Praveen Bhat

Active Director Designated Partner DIN 08886171
DIN 08886171 First appointment May 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Praveen Bhat

Data last updated:

Praveen Bhat is a Designated Partner at Megahorizon Healthcare Llp (since 2021). The company operates in Healthcare.

DIN 08886171
Primary Designation Designated Partner
Industry Healthcare
First Appointment 04 May 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner04 May 20212021Active

Directorship timeline

Open interactive timeline →
Megahorizon Healthcare Llp
Premium access

Shareholding and investment profile for Praveen Bhat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Praveen Bhat

Praveen Bhat currently holds 1 directorship: Megahorizon Healthcare Llp (Designated Partner, since 04 May 2021).

Praveen Bhat was first appointed on 04 May 2021 as Designated Partner at Megahorizon Healthcare Llp.

The current boards of Praveen Bhat's companies include Damodar Ramnath Lotlikar (Megahorizon Healthcare Llp), Madhavi Rajaram Mahambrey (Megahorizon Healthcare Llp), Maria Aurelia Albuquerque (Megahorizon Healthcare Llp), Neena Vishwajit Faldesai (Megahorizon Healthcare Llp), Oween Jose Albuquerque (Megahorizon Healthcare Llp), Rajaram Jagannath Mahambrey (Megahorizon Healthcare Llp), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available